Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Gajate, Consuelo ^a,b   Gonzalez Camacho, Fernando ^a   Mollinedo, Faustino ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EDELFOSINE; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; PROCASPASE 8; RNA; ANTINEOPLASTIC AGENT; CASPASE 8; ETHER PHOSPHOLIPID; FADD PROTEIN, HUMAN; MEMBRANE LIPID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME INHIBITION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LEUKEMIA CELL LINE; LIPID RAFT; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; FLUORESCENCE MICROSCOPY; METABOLISM; NICK END LABELING; PATHOLOGY; T CELL LEUKEMIA;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 8; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; IN SITU NICK-END LABELING; JURKAT CELLS; LEUKEMIA, T-CELL; MEMBRANE LIPIDS; MICROSCOPY, FLUORESCENCE; PHOSPHOLIPID ETHERS; SIGNAL TRANSDUCTION;

EID: 64549139703     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005044     Document Type: Article

References (36)

1. 3 induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells. Blood 98: 3860-3863.
2. Hueber AO, Bernard AM, Herincs Z, Couzinet A, He HT (2002) An essential role for membrane rafts in the initiation of Fas/CD95-triggered cell death in mouse thymocytes. EMBO Rep 3: 190-196.
3. Scheel-Toellner D, Wang K, Singh R, Majeed S, Raza K, et al. (2002) The death-inducing signalling complex is recruited to lipid rafts in Fas-induced apoptosis. Biochem Biophys Res Commun 297: 876-879.
4. Gajate C, Del Canto-Janez E, Acuna AU, Amat-Guerri F, Geijo E, et al. (2004) Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis. J Exp Med 200: 353-365.
5. Gajate C, Mollinedo F (2005) Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy. J Biol Chem 280: 11641-11647.
6. Mollinedo F, Gajate C (2006) Fas/CD95 death receptor and lipid rafts: New targets for apoptosis-directed cancer therapy. Drug Resist Updat 9: 51-73.
7. Gajate C, Mollinedo F (2007) Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. Blood 109: 711-719.
8. Mollinedo F, Gajate C (2006) FasL-independent activation of Fas. In: Wajant H, ed. Fas Signaling. Georgetown, TX: Landes Bioscience and Springer Science, Chapter 2. pp 13-27.
9. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, et al. (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809.
10. Tanaka M, Suda T, Yatomi T, Nakamura N, Nagata S (1997) Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes. J Immunol 158: 2303-2309.
11. Mollinedo F (2007) Antitumor ether lipids: proapoptotic agents with multiple therapeutic indications. Expert Opin Ther Patents 17: 385-405.
12. L. Cancer Res 57: 1320-1328.
13. Mollinedo F, Gajate C, Modolell M (1994) The ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine induces expression of fos and jun proto-oncogenes and activates AP-1 transcription factor in human leukaemic cells. Biochem J 302: 325-329.
14. 2-terminal kinase activation and c-Jun in the induction of apoptosis by the ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3- phosphocholine. Mol Pharmacol 53: 602-612.
15. Ruiter GA, Zerp SF, Bartelink H, van Blitterswijk WJ, Verheij M (1999) Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. Cancer Res 59: 2457-2463.
16. Gajate C, Fonteriz RI, Cabaner C, Alvarez-Noves G, Alvarez-Rodriguez Y, et al. (2000) Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis. Int J Cancer 85: 674-682.
17. 3-induced apoptosis of human leukemic cells. Int J Cancer 86: 208-218.
18. Nieto-Miguel T, Fonteriz RI, Vay L, Gajate C, Lopez-Hernandez S, et al. (2007) Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells. Cancer Res 67: 10368-10378.
19. Nieto-Miguel T, Gajate C, Mollinedo F (2006) Differential targets and subcellular localization of antitumor alkyl-lysophospholipid in leukemic versus solid tumor cells. J Biol Chem 281: 14833-14840.
20. Peter ME, Krammer PH (2003) The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 10: 26-35.
21. Delmas D, Rebe C, Lacour S, Filomenko R, Athias A, et al. (2003) Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. J Biol Chem 278: 41482-41490.
22. Schon A, Freire E (1989) Thermodynamics of intersubunit interactions in cholera toxin upon binding to the oligosaccharide portion of its cell surface receptor, ganglioside GM1. Biochemistry 28: 5019-5024.
23. Cheng PC, Dykstra ML, Mitchell RN, Pierce SK (1999) A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J Exp Med 190: 1549-1560.
24. Harder T, Scheiffele P, Verkade P, Simons K (1998) Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol 141: 929-942.
25. Hofmann TG, Moller A, Hehner SP, Welsch D, Droge W, et al. (2001) CD95-induced JNK activation signals are transmitted by the death-inducing signaling complex (DISC), but not by Daxx. Int J Cancer 93: 185-191.
26. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501.
27. Christian AE, Haynes MP, Phillips MC, Rothblat GH (1997) Use of cyclodextrins for manipulating cellular cholesterol content. J Lipid Res 38: 2264-2272.
28. Kelley EE, Modest EJ, Burns CP (1993) Unidirectional membrane uptake of the ether lipid antineoplastic agent edelfosine by L1210 cells. Biochem Pharmacol 45: 2435-2439.
29. Tsutsumi T, Tokumura A, Kitazawa S (1998) Undifferentiated HL-60 cells internalize an antitumor alkyl ether phospholipid more rapidly than resistant K562 cells. Biochim Biophys Acta 1390: 73-84.
30. Zaremberg V, Gajate C, Cacharro LM, Mollinedo F, McMaster CR (2005) Cytotoxicity of an anti-cancer lysophospholipid through selective modification of lipid raft composition. J Biol Chem 280: 38047-38058.
31. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM (1998) An induced proximity model for caspase-8 activation. J Biol Chem 273: 2926-2930.
32. Gajate C, An F, Mollinedo F (2003) Rapid and selective apoptosis in human leukemic cells induced by Aplidine through a Fas/CD95- and mitochondrial-mediated mechanism. Clin Cancer Res 9: 1535-1545.
33. Lacour S, Hammann A, Grazide S, Lagadic-Gossmann D, Athias A, et al. (2004) Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. Cancer Res 64: 3593-3598.
34. van der Luit AH, Vink SR, Klarenbeek JB, Perrissoud D, Solary E, et al. (2007) A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells. Mol Cancer Ther 6: 2337-2345.
35. 3: involvement of the Fas receptor/ligand system. Br J Pharmacol 127: 813-825.
36. Mollinedo F, Martin-Martin B, Calafat J, Nabokina SM, Lazo PA (2003) Role of vesicle-associated membrane protein-2, through Q-soluble N-ethylmaleimide-sensitive factor attachment protein receptor/ R-soluble N-ethylmaleimide-sensitive factor attachment protein receptor interaction, in the exocytosis of specific and tertiary granules of human neutrophils. J Immunol 170: 1034-1042.